Inge Winter van Rossum

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

René S. Kahn, Inge Winter van Rossum, Stefan Leucht et al. · The Lancet Psychiatry · 2018 · 190 citations

First-episode Schizophrenia, Psychiatry, Psychotic Disorder +11

Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning

Paola Bucci, Armida Mucci, Inge Winter van Rossum et al. · European Neuropsychopharmacology · 2020 · 44 citations

Psychological Co-morbidities, Psychiatric Disorders, Mental Health +17

Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study

Arsime Demjaha, Silvana Galderisi, Birthe Glenthøj et al. · Psychological Medicine · 2022 · 21 citations · Full text

The effects of the COVID-19 outbreak and measures in patients with a pre-existing psychiatric diagnosis: A cross-sectional study

Conrad E. Vissink, Hendrika H. van Hell, Niek Galenkamp et al. · Journal of Affective Disorders Reports · 2021 · 19 citations · Full text

Priorities, Satisfaction and Treatment Goals in Psychosis Patients: An Online Consumer's Survey

Bouke Sterk, Inge Winter van Rossum, Muslina Muis et al. · Pharmacopsychiatry · 2012 · 18 citations